Follow
Dr Surinder M Soond, PhD, FRSB
Dr Surinder M Soond, PhD, FRSB
Lecturer/PI (Immune-Oncology, University of Surrey), Honorary Professor (Sechenov University)
Verified email at surrey.ac.uk
Title
Cited by
Cited by
Year
Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury
L Valentim, KM Laurence, PA Townsend, CJ Carroll, S Soond, ...
Journal of molecular and cellular cardiology 40 (6), 846-852, 2006
3662006
ERK-mediated phosphorylation of Thr735 in TNFα-converting enzyme and its potential role in TACE protein trafficking
SM Soond, B Everson, DWH Riches, G Murphy
Journal of cell science 118 (11), 2371-2380, 2005
3172005
Analyzing mRNA expression identifies Smad3 as a microRNA-140 target regulated only at protein level
H Pais, FE Nicolas, SM Soond, TE Swingler, IM Clark, A Chantry, ...
Rna 16 (3), 489-494, 2010
1592010
The biological basis and clinical symptoms of CAR-T therapy-associated toxicites
A Titov, A Petukhov, A Staliarova, D Motorin, E Bulatov, O Shuvalov, ...
Cell death & disease 9 (9), 897, 2018
1172018
Albumin nanovectors in cancer therapy and imaging
A Parodi, J Miao, SM Soond, M Rudzińska, AA Zamyatnin Jr
Biomolecules 9 (6), 218, 2019
1052019
The role of cysteine cathepsins in cancer progression and drug resistance
M Rudzińska, A Parodi, SM Soond, AZ Vinarov, DO Korolev, AO Morozov, ...
International journal of molecular sciences 20 (14), 3602, 2019
1002019
Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT
SM Soond, A Chantry
Oncogene 30 (21), 2451-2462, 2011
1002011
Established and emerging strategies for drug delivery across the blood-brain barrier in brain cancer
A Parodi, M Rudzińska, AA Deviatkin, SM Soond, AV Baldin, ...
Pharmaceutics 11 (5), 245, 2019
632019
ERK and the F-box protein βTRCP target STAT1 for degradation
SM Soond, PA Townsend, SP Barry, RA Knight, DS Latchman, ...
Journal of biological chemistry 283 (23), 16077-16083, 2008
562008
New targets of urocortin-mediated cardioprotection
SP Barry, KM Lawrence, J McCormick, SM Soond, M Hubank, S Eaton, ...
Journal of Molecular Endocrinology 45 (2), 69-85, 2010
512010
BH3-mimetics: recent developments in cancer therapy
PA Townsend, MV Kozhevnikova, ONF Cexus, AA Zamyatnin, SM Soond
Journal of experimental & clinical cancer research 40, 1-33, 2021
492021
Cysteine cathepsin protease inhibition: an update on its diagnostic, prognostic and therapeutic potential in cancer
SM Soond, MV Kozhevnikova, PA Townsend, AA Zamyatnin Jr
Pharmaceuticals 12 (2), 87, 2019
482019
Early phase TGFβ receptor signalling dynamics stabilised by the deubiquitinase UCH37 promotes cell migratory responses
AJ Cutts, SM Soond, S Powell, A Chantry
The international journal of biochemistry & cell biology 43 (4), 604-612, 2011
452011
TRUSS, a novel tumor necrosis factor receptor 1 scaffolding protein that mediates activation of the transcription factor NF-κB
SM Soond, JL Terry, JD Colbert, DWH Riches
Molecular and cellular biology, 2003
402003
STAT1 regulates p73-mediated Bax gene expression
SM Soond, C Carroll, PA Townsend, E Sayan, G Melino, I Behrmann, ...
Febs Letters 581 (6), 1217-1226, 2007
392007
The DNA and RNA polymerase genes of yeast plasmid pGKL2 are essential loci for plasmid integrity and maintenance
R Schaffrath, SM Soond, PA Meacock
Microbiology 141 (10), 2591-2599, 1995
371995
How ubiquitination regulates the TGF‐β signalling pathway: New insights and new players: New isoforms of ubiquitin‐activating enzymes in the E1‐E3 families join the game
SM Soond, A Chantry
Bioessays 33 (10), 749-758, 2011
332011
Kluyveromyces lactis killer plasmid pGKL2: Molecular analysis of an essential gene, ORF5
R Schaffrath, PA Meacock
Yeast 11 (7), 615-628, 1995
311995
Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets in cancer
SM Soond, PG Smith, L Wahl, TE Swingler, IM Clark, AM Hemmings, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832 (12 …, 2013
302013
p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1
SM Soond, S Barry, G Melino, RA Knight, DS Latchman, A Stephanou
Cell Cycle 7 (9), 1214-1223, 2008
282008
The system can't perform the operation now. Try again later.
Articles 1–20